Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jun 23, 2015 (11 years ago)

Cortisol-Mc

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Content Uniformity Specifications: Failed Uniformity of Dosage Units specifications.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

CORTISOL-MC, 10mg CAP, packaged in 30 and 90 count bottles, Rx Only, ABRAMS ROYAL pharmacy II, 4909 W Park Blvd, Suite 177, Plano, TX 75093 --- NDC 88888-0043-31

Affected NDC 88888-0043-31

Compare with the code on your package — it is the most precise check available.

Recalling firm
Abrams Royal Pharmacy II, LLC
NDC code
88888-0043-31
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1231-2015 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other wrong potency / content recalls from 2015

All wrong potency / content recalls
Class III · Low risk

NORepinephrine Bitartrate

Subpotent Drug; confirmed results by FDA analysis after customer complaints of discoloration

Terminated Wrong potency / content Pharmedium Services, LLC NDC 61553-127-61 D-0778-2016
Class III · Low risk

NORepinephrine Bitartrate

Subpotent Drug; confirmed results by FDA analysis after customer complaints of discoloration

Terminated Wrong potency / content Pharmedium Services, LLC NDC 61553-134-61 D-0777-2016
Class III · Low risk

Lindane Lotion

Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.

Terminated Wrong potency / content Morton Grove Pharmaceuticals, Inc. NDC 60432-833-60 D-0571-2016
Class I · High risk

Vitamin Supplement

Superpotent Drug: The vitamin supplement contains an extremely high level of vitamin D3 (Cholecalciferol).

Ongoing Wrong potency / content Glades Drugs Inc. D-0669-2016